Hostname: page-component-8448b6f56d-dnltx Total loading time: 0 Render date: 2024-04-18T16:47:46.066Z Has data issue: false hasContentIssue false

Prevalence of Atherogenic Profile and Heart Failure in Vascular Dementia

Published online by Cambridge University Press:  15 April 2020

D. Matei
Affiliation:
Faculty of Biomedical Engineering Biomedical Sciences, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
C. Corciova
Affiliation:
Faculty of Biomedical Engineering Biomedical Sciences, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
D. Zaharia
Affiliation:
Faculty of Biomedical Engineering Biomedical Sciences, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania
C.D. Popescu
Affiliation:
Faculty of General Medicine Department of Neurology, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objectives

Purpose of our study was to evaluate the incidence of atherogenic profile, heart failure (HF) and if there is any correlation between these and cognitive impairment (CI) in patients with vascular dementia (VaD).

Method

This was a retrospective study. We analyzed 35 patients with VaD and 25 age- and sex-matched healthy controls. NINDS-AIREN criteria and Hachinski's ischemic scale were used to identify VaD. Mini Mental State Examination was used to classify CI into mild, moderate and severe. Clinical and biochemical features were investigated by means of standardized tests. Echocardiography was done for evaluate ejection fraction (EF).

Results

Prevalence of atherogenic profile was increased in VaD compared with controls (72.2% vs 20%, p<0.001). High LDL cholesterol, triglicerides and low HDL cholesterol values were characteristic for VaD patients in the last 10 years. In present time we found low level for HDL cholesterol (34.1± 4.6 mg/dl vs 44.2± 5.8 mg/dl, p<0.001) and triglicerides (102.7± 7.5 mg/dl vs 154.2± 4.5 mg/dl, p<0.01) when compared with controls. 8 patients had mild CI, 2 of them had HF class II and 6 had class III NYHA, with EF in normal limits. 23 patients had moderate CI and low EF; 7 of them had HF class III and 16 had class IV NYHA. 4 patients with severe CI had very low EF and HF class IV NYHA. We found correlations between EF, triglicerides and CI.

Conclusions

The prevalence of atherogenic profile and heart failure were significantly higher in VaD and were correlated with cognitive impairment.

Type
Article: 0594
Copyright
Copyright © European Psychiatric Association 2015
Submit a response

Comments

No Comments have been published for this article.